The amyloidogenic capacity of CARs in cancer-related proteins has also been demonstrated for peptides in p53 (326-EYFTLQIR-333) and retinoblastoma-associated protein (831-ILVSIGESFG-840) (Santos et al., 2021), both present in CARs-DB under the 85 and 80 thresholds, respectively. The gene discussed is TP53; the disease is cancer.